What is the appropriate dosing regimen for furosemide (Lasix) in adults with edema or hypertension, including oral and intravenous dosing, titration steps, maximum daily dose, and adjustments for impaired renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Furosemide (Lasix) Dosing in Adults

For adults with edema or heart failure, start furosemide at 20-40 mg orally once or twice daily, titrating upward by 20-40 mg increments every 3-5 days until adequate diuresis is achieved, with usual maximum doses of 160-600 mg/day depending on indication and renal function. 1, 2

Oral Dosing for Edema

Initial Dosing

  • Start with 20-40 mg once or twice daily for most patients with fluid retention 1, 2
  • Single morning dosing maximizes compliance 1
  • Even 20 mg daily produces significant diuretic and natriuretic effects in heart failure patients 3

Dose Titration

  • Increase by 20-40 mg increments every 3-5 days if weight loss and natriuresis are inadequate 1
  • Target weight loss of 0.5 kg/day in patients without edema and 1 kg/day in patients with edema 1
  • Continue titration until clinical evidence of fluid retention resolves 1

Maximum Doses

  • Standard maximum: 160-240 mg/day for most heart failure patients 1
  • Absolute maximum: 600 mg/day in refractory cases 1, 2
  • Higher doses (up to 720 mg/day orally) have been used safely in resistant edematous states 4

Intravenous Dosing

Acute Edema

  • Initial IV dose: 20-40 mg given slowly over 1-2 minutes 2
  • If inadequate response after 2 hours, may increase by 20 mg increments 2
  • Maximum rate for IV infusion: 4 mg/min to prevent ototoxicity 2

Acute Pulmonary Edema

  • Initial dose: 40 mg IV slowly over 1-2 minutes 2
  • If inadequate response within 1 hour, increase to 80 mg IV slowly 2

High-Dose IV Therapy

  • For severe heart failure: 40 mg IV load, then 10-40 mg/hour continuous infusion 1
  • Total furosemide should remain <100 mg in first 6 hours and <240 mg in first 24 hours 1
  • Must be diluted in alkaline solution (pH >5.5) and infused at ≤4 mg/min 2

Adjustments for Renal Impairment

Chronic Kidney Disease

  • In patients with creatinine clearance <20 mL/min, single IV doses of 120-160 mg reach maximal response 5
  • No need for single doses exceeding 160 mg IV in severe renal insufficiency 5
  • Oral doses may need to be higher (up to 720 mg/day) due to reduced bioavailability 4

Cirrhosis with Ascites

  • Start with spironolactone 100 mg/day alone for first episode of moderate ascites 1
  • If inadequate response, add furosemide starting at 40 mg/day 1
  • Increase both drugs simultaneously maintaining 100:40 mg ratio (spironolactone:furosemide) every 3-5 days 1
  • Usual maximum: spironolactone 400 mg/day with furosemide 160 mg/day 1

Combination Therapy

Sequential Nephron Blockade

  • For diuretic resistance, add metolazone 2.5-10 mg once daily or hydrochlorothiazide 25-100 mg once or twice daily to loop diuretic 1
  • Alternatively, chlorothiazide 500-1000 mg IV can be combined with loop diuretics 1
  • Monitor electrolytes closely as combination therapy markedly enhances risk of depletion 1

Monitoring Requirements

Initial Phase

  • Frequent clinical and biochemical monitoring during first weeks of treatment, particularly on first presentation 1
  • Measure serum creatinine, sodium, and potassium shortly after initiating therapy and periodically thereafter 1

Ongoing Monitoring

  • Daily weights with patient-directed dose adjustments based on specified weight range 1
  • Assess for signs of volume depletion (hypotension, azotemia) versus persistent congestion 1

Critical Safety Considerations

Contraindications and Cautions

  • Discontinue if severe hyponatremia (<125 mmol/L), acute kidney injury, worsening hepatic encephalopathy, or incapacitating muscle cramps develop 1
  • Stop furosemide if severe hypokalemia (<3 mmol/L) occurs 1
  • Avoid in patients with systolic blood pressure <90 mmHg 1
  • Use cautiously with loop-inhibiting diuretics due to increased ototoxicity risk 1

Electrolyte Management

  • Concomitant ACE inhibitors or aldosterone antagonists can prevent potassium depletion and often eliminate need for long-term potassium supplementation 1
  • When ACE inhibitors/aldosterone antagonists are prescribed, long-term oral potassium supplementation may be deleterious 1

Renal Considerations

  • IV furosemide 80 mg can cause acute reduction in renal perfusion and azotemia in cirrhosis patients 1
  • Recent evidence suggests furosemide may exacerbate renal damage following ischemic injury and should be used with caution in perioperative AKI 6

Pediatric Dosing (for reference)

  • Initial: 0.5-2.0 mg/kg/day 1
  • Maximum: 6 mg/kg/day 1
  • Dosed once or twice daily 1

Related Questions

What is the best approach to manage hypotension in a patient taking furosemide?
In an adult with chronic congestive heart failure who is volume overloaded, with systolic blood pressure ≥90 mm Hg, serum creatinine ≤2.5 mg/dL (estimated glomerular filtration rate ≥30 mL/min/1.73 m²), and serum potassium ≤5.0 mmol/L, can I administer furosemide 80 mg now?
What is the appropriate starting dose of furosemide (Lasix) for a 39-year-old woman with heart‑failure‑related peripheral edema?
What furosemide dose is recommended for fluid overload in a patient with impaired renal function (eGFR 34 mL/min/1.73 m²), elevated serum sodium (144 mEq/L), and hyperkalemia (5.8 mEq/L)?
What is the appropriate initial dose, titration, and monitoring plan for prescribing furosemide to an adult patient with symptomatic volume overload?
Should serum total protein and albumin be measured in a patient with lower-extremity edema?
Which laboratory tests should be ordered to screen for Cushing syndrome in a patient on chronic prednisone after tapering the steroid?
What is the significance and recommended management for a liver stiffness measurement of 15.5 kPa and a CAP (controlled attenuation parameter) median of 286 dB/m?
What is the minimum platelet count required for safe spinal (neuraxial) anesthesia in an adult?
What does a low METs (metabolic equivalents) result on a treadmill stress test indicate and what are the recommended next steps?
What is the appropriate treatment for ascariasis in a pregnant patient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.